Skip to main content
TipRanks
Go Ultimate75% OFF

Microbot Medical (MBOT) Stock Statistics & Valuation Metrics

1,233 Followers

Total Valuation

Microbot Medical has a market cap or net worth of $49.92M. The enterprise value is $82.91T.

Market Cap
$49.92M
Enterprise Value
$82.91T

Share Statistics

Microbot Medical has 67,164,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
67,164,800
Owned by Insiders
0.20%
Owned by Institutions
13.03%

Financial Efficiency

Microbot Medical’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -18.80%.

Return on Equity (ROE)
-0.17
Return on Assets (ROA)
-0.16
Return on Invested Capital (ROIC)
-18.80%
Return on Capital Employed (ROCE)
-0.19
Revenue Per Employee
0
Profits Per Employee
-305.63K
Employee Count
43
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Microbot Medical is -2.49. Microbot Medical’s PEG ratio is -0.04.

PE Ratio
-2.49
PS Ratio
109.26
PB Ratio
0.72
Price to FCF
-2.33
Price to Operating Cash Flow
-2.38
PEG Ratio
-0.04

Income Statement

In the last 12 months, Microbot Medical had revenue of 0 and earned -13.14M in profits. Earnings per share was -0.29.

Revenue
0
Gross Profit
0
Operating Income
-14.74M
Pretax Income
-13.14M
Net Income
-13.14M
EBITDA
-13.10M
Earnings Per Share (EPS)
-0.29

Cash Flow

In the last 12 months, operating cash flow was -19.21M and capital expenditures -390,000, giving a free cash flow of -19.60M billion.

Operating Cash Flow
-19.21M
Free Cash Flow
-19.60M
Free Cash Flow per Share
-0.29

Dividends & Yields

Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-43.03%
Earnings Yield
-40.85%

Stock Price Statistics

Beta
1.61
52-Week Price Change
-60.69%
50-Day Moving Average
1.12
200-Day Moving Average
1.79
Relative Strength Index (RSI)
33.34
Average Volume (3m)
915.94K

Financial Position

Microbot Medical as a current ratio of 23.33, with Debt / Equity ratio of 1.12%

Current Ratio
23.33
Quick Ratio
23.16
Debt to Market Cap
0.00
Net Debt to EBITDA
0.23
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Microbot Medical has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Microbot Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of -2.25.

EV to Sales
105.46
EV to EBITDA
-2.30
EV to Free Cash Flow
-2.25
EV to Operating Cash Flow
-2.30

Balance Sheet

Microbot Medical has $61.83M in cash and marketable securities with $838.00K in debt, giving a net cash position of $60.99M billion.

Cash & Marketable Securities
$61.83M
Total Debt
$838.00K
Net Cash
$60.99M
Net Cash Per Share
$0.91
Tangible Book Value Per Share
$0.94

Margins

Gross margin is -404.78%, with operating margin of -5057.42%, and net profit margin of -4450.72%.

Gross Margin
-404.78%
Operating Margin
-5057.42%
Pretax Margin
-4450.72%
Net Profit Margin
-4450.72%
EBITDA Margin
-4591.15%
EBIT Margin
-4606.70%

Analyst Forecast

The average price target for Microbot Medical is $5.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$5.00
Price Target Upside
635.29% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
―
EPS Growth Forecast
38.89%

Scores

Smart Score
6
AI Score
―